About
Us

AnHeart is a global oncology-focused clinical stage biopharmaceutical company operating in both China and the United States.

Currently, the company is developing three promising clinical stage oncology therapeutics.

Leadership

Our leadership team has extensive experience in global clinical drug development and business development.

Management

Junyuan Wang

Junyuan Jerry Wang, Ph.D.

Co-Founder & CEO

Bing Yan, M.D., MBA

Co-Founder & Chief Medical Officer

Lihua Zheng

Lihua Zheng, J.D., Ph.D.

Co-Founder & Chief Business Officer

Frank Fan

Fan Frank Fan, M.D., MBA

Senior Vice President & Head of Clinical Development Strategy

Dagang Doug Chen

Dagang Doug Chen, Ph.D.

Senior Vice President of CMC & General Manager of Hangzhou Site

Qinying Zhao

Qinying Zhao, Ph.D.

Vice President of Clinical Pharmacology

Board of Directors

Tony Tong
Xiaohang Tony Tong, Ph.D.
Wei Xu
Wei Xu
Zhengwei Zhu
Zhengwei Zhu
Junyuan Wang
Junyuan Jerry Wang, Ph.D.
Bing Yan, M.D., MBA

Scientific Advisory Board

Takashi Seto
Takashi Seto, M.D.
Sai-Hong Ignatius Ou
Sai-Hong Ignatius Ou M.D., Ph.D.
Caicun Zhou
Caicun Zhou, M.D., Ph.D.
David A. Reardon, M.D.

Investors

Decheng Capital

Partners

Daiichi-Sankyo
Newglab Pharma
For partnering opportunities, please contact:
bd@anhearttherapeutics.com